Medherant
is an England-based clinical-stage company that researches and develops transdermal drug delivery systems for central nervous system diseases... Read moreMedherant
is an England-based clinical-stage company that researches and develops transdermal drug delivery systems for central nervous system diseases... Read more
News
Oct 28, 2025
PMLiVE
Medherant: Medherant announces positive phase 1 results for testosterone patch for women
Apr 06, 2023
ExploreBit
Medherant: Medherant Raises GBP 3M Funding
Apr 04, 2023
FinSMEs
Medherant: Medherant Raises 3M in Funding
Jun 01, 2020
Manufacturing Chemist
Medherant: Cycle Pharmaceuticals and Medherant partner on transdermal delivery tech
May 14, 2020
Business and Innovation Magazine
Medherant: Coventry drug tech company signs partnership deal with rare disease pharma
May 05, 2020
MarketScreener
Medherant: Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch Technology
Dec 12, 2019
BioPortfolio
Medherant: Medherant Ltd Product Pipeline Analysis 2019 Update Published by Global Data Prices from USD $660
Jul 09, 2019
Manufacturing Chemist
Medherant: Medherant appoints new CEO
May 22, 2019
PharmaTech
Medherant: New Investment in Medherant Set to Advance Patch Tech to Clinical Development
Nov 10, 2018
Pharmabiz
Medherant: Medherant completes two phase I studies with novel Ibuprofen TEPI Patch
Medherant Competitors
1
2
3
4
5
6
7
8
9
10